In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Albany Molecular Research completes $46.5mm IPO

Executive Summary

Albany Molecular Research, a chemistry outsourcing company, netted $46.5mm in a 2.5mm share IPO at $20 each. Originally the offering was for 2.2mm shares at $17-19 apiece, but the offering was increased to meet investor demand.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies